nProfiler 1

· Novomics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for nProfiler 1, covering 2024-12-17 to 2024-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer